ESC 365 - Restricted mean survival time analysis in heart failure clinical trials

ESC Premium Access

Restricted mean survival time analysis in heart failure clinical trials

Session: Novel Pharmacotherapies and Surgical Procedures for Heart Failure: How To Succeed?

Topic: Treatment

Speaker: Doctor C. Perego (Cinisello Balsamo, IT)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Carlotta Perego

Bassini Hospital, Cinisello Balsamo (Italy)

0 follower

6 more presentations in this session

Independent predictors of heart failure in patients with type 2 diabetes and chronic kidney disease: modeling from the CREDENCE trial

Speaker: Doctor A. Sarraju (Stanford, US)

Serum uric acid, influence of sacubitril/valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF

Speaker: Doctor S. Selvaraj (Durham, US)

The renal and cardiovascular effects of SGLT2 inhibition in combination with loop diuretics in patients with type 2 diabetes and chronic heart failure (RECEDE-CHF) trial

Speaker: Doctor N. Mordi (Dundee, GB)

Hybrid transcatheter and minimally invasive left ventricular reconstruction for the treatment of ischemic cardiomyopathy: mid-term results

Speaker: Doctor P. Klein (Nieuwegein, NL)

LIVE procedure for ischemic heart failure: the evolution of an unique technique

Speaker: Doctor P. Neves (Vila Nova de Gaia, PT)

Access the full session

Novel Pharmacotherapies and Surgical Procedures for Heart Failure: How To Succeed?

Speakers: Doctor C. Perego, Doctor A. Sarraju, Doctor S. Selvaraj, Doctor N. Mordi, Doctor P. Klein...

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources